• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道菌群失调衍生代谢物及其在非传染性疾病中的作用。

Dysbiotic Gut Microbiota-Derived Metabolites and Their Role in Non-Communicable Diseases.

机构信息

Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia.

School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.

出版信息

Int J Mol Sci. 2023 Oct 17;24(20):15256. doi: 10.3390/ijms242015256.

DOI:10.3390/ijms242015256
PMID:37894934
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10607102/
Abstract

Dysbiosis, generally defined as the disruption to gut microbiota composition or function, is observed in most diseases, including allergies, cancer, metabolic diseases, neurological disorders and diseases associated with autoimmunity. Dysbiosis is commonly associated with reduced levels of beneficial gut microbiota-derived metabolites such as short-chain fatty acids (SCFA) and indoles. Supplementation with these beneficial metabolites, or interventions to increase their microbial production, has been shown to ameliorate a variety of inflammatory diseases. Conversely, the production of gut 'dysbiotic' metabolites or by-products by the gut microbiota may contribute to disease development. This review summarizes the various 'dysbiotic' gut-derived products observed in cardiovascular diseases, cancer, inflammatory bowel disease, metabolic diseases including non-alcoholic steatohepatitis and autoimmune disorders such as multiple sclerosis. The increased production of dysbiotic gut microbial products, including trimethylamine, hydrogen sulphide, products of amino acid metabolism such as p-Cresyl sulphate and phenylacetic acid, and secondary bile acids such as deoxycholic acid, is commonly observed across multiple diseases. The simultaneous increased production of dysbiotic metabolites with the impaired production of beneficial metabolites, commonly associated with a modern lifestyle, may partially explain the high prevalence of inflammatory diseases in western countries.

摘要

肠道菌群失调通常被定义为肠道微生物群落组成或功能的紊乱,在大多数疾病中都有观察到,包括过敏、癌症、代谢疾病、神经紊乱和自身免疫性疾病。肠道菌群失调通常与有益的肠道微生物衍生代谢物水平降低有关,如短链脂肪酸 (SCFA) 和吲哚。补充这些有益的代谢物,或干预措施以增加其微生物产生,已被证明可以改善各种炎症性疾病。相反,肠道微生物群产生的肠道“失调”代谢物或副产物可能有助于疾病的发展。这篇综述总结了在心血管疾病、癌症、炎症性肠病、代谢疾病(包括非酒精性脂肪性肝炎)和自身免疫性疾病(如多发性硬化症)中观察到的各种“失调”肠道来源的产物。失调的肠道微生物产物的产量增加,包括三甲胺、硫化氢、氨基酸代谢产物如对甲酚硫酸盐和苯乙酸,以及次级胆汁酸如脱氧胆酸,在多种疾病中都有观察到。与现代生活方式相关的有益代谢物产生受损的同时,失调代谢物的同时产生,可能部分解释了西方国家炎症性疾病的高发率。

相似文献

1
Dysbiotic Gut Microbiota-Derived Metabolites and Their Role in Non-Communicable Diseases.肠道菌群失调衍生代谢物及其在非传染性疾病中的作用。
Int J Mol Sci. 2023 Oct 17;24(20):15256. doi: 10.3390/ijms242015256.
2
Interplay between Dysbiosis of Gut Microbiome, Lipid Metabolism, and Tumorigenesis: Can Gut Dysbiosis Stand as a Prognostic Marker in Cancer?肠道微生物组失调、脂代谢与肿瘤发生的相互作用:肠道微生物组失调能否成为癌症的预后标志物?
Dis Markers. 2022 Feb 8;2022:2941248. doi: 10.1155/2022/2941248. eCollection 2022.
3
METABOLIC DYSBIOSIS OF THE GUT MICROBIOTA AND ITS BIOMARKERS.肠道微生物群的代谢失调及其生物标志物
Eksp Klin Gastroenterol. 2016 Jul;12(12):6-29.
4
The Effect of Dietary Types on Gut Microbiota Composition and Development of Non-Communicable Diseases: A Narrative Review.膳食类型对肠道微生物组成和非传染性疾病发展的影响:叙述性综述。
Nutrients. 2024 Sep 17;16(18):3134. doi: 10.3390/nu16183134.
5
Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.连接免疫系统、系统性慢性炎症和肠道微生物组:性别的作用。
J Autoimmun. 2018 Aug;92:12-34. doi: 10.1016/j.jaut.2018.05.008. Epub 2018 Jun 1.
6
The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases.肠道细菌代谢物在非传染性疾病的人类免疫信号通路中的作用。
Gut Microbes. 2021 Jan-Dec;13(1):1-22. doi: 10.1080/19490976.2021.1882927.
7
A gut dysbiotic microbiota-based hypothesis of human-to-human transmission of non-communicable diseases.基于肠道菌群失调的假说:非传染性疾病在人与人之间的传播。
Sci Total Environ. 2020 Nov 25;745:141030. doi: 10.1016/j.scitotenv.2020.141030. Epub 2020 Jul 21.
8
Bidirectional crosstalk between dysbiotic gut microbiota and systemic lupus erythematosus: What is new in therapeutic approaches?肠道菌群失调与系统性红斑狼疮的双向串扰:治疗方法有哪些新进展?
Clin Immunol. 2022 Nov;244:109109. doi: 10.1016/j.clim.2022.109109. Epub 2022 Sep 8.
9
Gut Microbiota and Cardiovascular Disease: Symbiosis Versus Dysbiosis.肠道微生物群与心血管疾病:共生与失调。
Curr Med Chem. 2022;29(23):4050-4077. doi: 10.2174/0929867328666211213112949.
10
Gut-microbiota derived bioactive metabolites and their functions in host physiology.肠道微生物衍生的生物活性代谢物及其在宿主生理学中的功能。
Biotechnol Genet Eng Rev. 2021 Oct;37(2):105-153. doi: 10.1080/02648725.2021.1989847. Epub 2021 Oct 22.

引用本文的文献

1
Gut microbiota-derived extracellular vesicles exhibit diurnal regulation and activate hepatic gluconeogenesis.肠道微生物群衍生的细胞外囊泡呈现昼夜节律调节并激活肝脏糖异生。
Mol Metab. 2025 Aug;98:102180. doi: 10.1016/j.molmet.2025.102180. Epub 2025 Jun 6.
2
Changes in the metabolome, lipidomein, and gut microbiota in Behçet's disease.白塞病中代谢组、脂质组和肠道微生物群的变化。
Front Cell Dev Biol. 2025 Mar 28;13:1530996. doi: 10.3389/fcell.2025.1530996. eCollection 2025.
3
Factors affecting dysbiosis of the gut microbiota in the elderly and the progress of interventions in traditional Chinese and Western medicine.影响老年人肠道微生物群失调的因素及中西医干预进展
Front Cell Infect Microbiol. 2025 Mar 24;15:1529347. doi: 10.3389/fcimb.2025.1529347. eCollection 2025.
4
Microbes Saving Lives and Reducing Suffering.微生物拯救生命,减轻痛苦。
Microb Biotechnol. 2025 Jan;18(1):e70068. doi: 10.1111/1751-7915.70068.
5
and the Human Gastrointestinal Microbiota: A Multifaceted Relationship.以及人类胃肠道微生物群:一种多方面的关系。
Antibiotics (Basel). 2024 Jun 24;13(7):584. doi: 10.3390/antibiotics13070584.
6
The role of the "gut microbiota-mitochondria" crosstalk in the pathogenesis of multiple sclerosis.“肠道微生物群-线粒体”串扰在多发性硬化症发病机制中的作用
Front Microbiol. 2024 Apr 29;15:1404995. doi: 10.3389/fmicb.2024.1404995. eCollection 2024.
7
Benefit of Dietary Supplementation of Nutraceuticals as an Integrative Approach for Management of Migraine: Evidence From Preclinical and Clinical Studies.营养保健品的膳食补充作为偏头痛管理的综合方法的益处:来自临床前和临床研究的证据。
Curr Pain Headache Rep. 2024 May;28(5):373-381. doi: 10.1007/s11916-024-01230-w. Epub 2024 Mar 2.
8
Gut microbiota-derived metabolites associate with circulating immune cell subsets in unexplained recurrent spontaneous abortion.肠道微生物群衍生的代谢产物与不明原因复发性自然流产中的循环免疫细胞亚群相关。
Heliyon. 2024 Jan 17;10(2):e24571. doi: 10.1016/j.heliyon.2024.e24571. eCollection 2024 Jan 30.

本文引用的文献

1
Diet, commensal microbiota-derived extracellular vesicles, and host immunity.饮食、共生菌衍生的细胞外囊泡与宿主免疫。
Eur J Immunol. 2023 Jul;53(7):e2250163. doi: 10.1002/eji.202250163. Epub 2023 May 17.
2
Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer.具核梭杆菌衍生的琥珀酸诱导结直肠癌对免疫治疗产生耐药性。
Cell Host Microbe. 2023 May 10;31(5):781-797.e9. doi: 10.1016/j.chom.2023.04.010. Epub 2023 May 1.
3
Editorial: Deciphering host-gut microbiota communication in immunity and disease.社论:解读宿主与肠道微生物群在免疫和疾病中的交流
Front Nutr. 2023 Mar 27;10:1178039. doi: 10.3389/fnut.2023.1178039. eCollection 2023.
4
Faecal metabolome and its determinants in inflammatory bowel disease.炎症性肠病的粪便代谢组及其决定因素。
Gut. 2023 Aug;72(8):1472-1485. doi: 10.1136/gutjnl-2022-328048. Epub 2023 Mar 23.
5
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer.微生物衍生的 3-吲哚乙酸影响胰腺癌的化疗疗效。
Nature. 2023 Mar;615(7950):168-174. doi: 10.1038/s41586-023-05728-y. Epub 2023 Feb 22.
6
Identification of Gut Microbial Lysine and Histidine Degradation and CYP-Dependent Metabolites as Biomarkers of Fatty Liver Disease.鉴定肠道微生物赖氨酸和组氨酸降解物及 CYP 依赖性代谢产物作为非酒精性脂肪性肝病的生物标志物。
mBio. 2023 Feb 28;14(1):e0266322. doi: 10.1128/mbio.02663-22. Epub 2023 Jan 30.
7
Intestinal dysbiosis exacerbates the pathogenesis of psoriasis-like phenotype through changes in fatty acid metabolism.肠道菌群失调通过改变脂肪酸代谢加剧银屑病样表型的发病机制。
Signal Transduct Target Ther. 2023 Jan 30;8(1):40. doi: 10.1038/s41392-022-01219-0.
8
Dietary fiber and SCFAs in the regulation of mucosal immunity.膳食纤维和短链脂肪酸对黏膜免疫的调节作用。
J Allergy Clin Immunol. 2023 Feb;151(2):361-370. doi: 10.1016/j.jaci.2022.11.007. Epub 2022 Dec 19.
9
Gut microbiota alterations promote traumatic stress susceptibility associated with p-cresol-induced dopaminergic dysfunctions.肠道微生物群改变会促进与对甲酚诱导的多巴胺能功能障碍相关的创伤应激易感性。
Brain Behav Immun. 2023 Jan;107:385-396. doi: 10.1016/j.bbi.2022.11.004. Epub 2022 Nov 15.
10
Aorta- and liver-generated TMAO enhances trained immunity for increased inflammation via ER stress/mitochondrial ROS/glycolysis pathways.主动脉和肝脏生成的 TMAO 通过内质网应激/线粒体 ROS/糖酵解途径增强训练免疫以增加炎症。
JCI Insight. 2023 Jan 10;8(1):e158183. doi: 10.1172/jci.insight.158183.